KalVista Pharmaceuticals

KALV

NASDAQHealth Care

Income Statement

Total Revenue$0

Gross Profit$0

Operating Income$-170.04M

EBITDA$-153.71M

EBIT$-154.56M

Pre-tax Income$-85.94M

Net Income$-154.56M

Cash Equivalent$67.25M

Total Debt$5.42M

Book Value$158.08M

Book Value Per Share3.74

Return on Equity (ROE)-61.30%

Return on Assets (ROA)-53.80%

Return on Invested Capital (ROI)-61.30%

Net Profit Margin-229.47%

Current Ratio5.35

Quick Ratio4.98

Long-Term Debt / Equity1.11